BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 17909011)

  • 1. TREX2 enables efficient genome disruption mediated by paired CRISPR-Cas9 nickases that generate 3'-overhanging ends.
    Wang Y; Feng YL; Liu Q; Xiao JJ; Liu SC; Huang ZC; Xie AY
    Mol Ther Nucleic Acids; 2023 Dec; 34():102072. PubMed ID: 38028195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer.
    Manils J; Marruecos L; Soler C
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.
    Funt SA; Rosenberg JE
    Nat Rev Clin Oncol; 2017 Apr; 14(4):221-234. PubMed ID: 27874062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism for 1,4-Benzoquinone-induced genotoxicity.
    Son MY; Deng CX; Hoeijmarkers JH; Rebel VI; Hasty P
    Oncotarget; 2016 Jul; 7(29):46433-46447. PubMed ID: 27340773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaceted role of TREX2 in the skin defense against UV-induced skin carcinogenesis.
    Manils J; Gómez D; Salla-Martret M; Fischer H; Fye JM; Marzo E; Marruecos L; Serrano I; Salgado R; Rodrigo JP; Garcia-Pedrero JM; Serafin AM; Cañas X; Benito C; Toll A; Forcales SV; Perrino FW; Eckhart L; Soler C
    Oncotarget; 2015 Sep; 6(26):22375-96. PubMed ID: 26090614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway.
    Kim TM; Son MY; Dodds S; Hu L; Luo G; Hasty P
    Nucleic Acids Res; 2015 Jan; 43(2):893-903. PubMed ID: 25520194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two replication fork maintenance pathways fuse inverted repeats to rearrange chromosomes.
    Hu L; Kim TM; Son MY; Kim SA; Holland CL; Tateishi S; Kim DH; Yew PR; Montagna C; Dumitrache LC; Hasty P
    Nature; 2013 Sep; 501(7468):569-72. PubMed ID: 24013173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining a genotoxic profile with mouse embryonic stem cells.
    Kim TM; Rebel VI; Hasty P
    Exp Biol Med (Maywood); 2013 Mar; 238(3):285-93. PubMed ID: 23598974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAD51 mutants cause replication defects and chromosomal instability.
    Kim TM; Ko JH; Hu L; Kim SA; Bishop AJ; Vijg J; Montagna C; Hasty P
    Mol Cell Biol; 2012 Sep; 32(18):3663-80. PubMed ID: 22778135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the fanconi anemia pathway to identify tailored anticancer therapeutics.
    Jenkins C; Kan J; Hoatlin ME
    Anemia; 2012; 2012():481583. PubMed ID: 22693661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trex2 enables spontaneous sister chromatid exchanges without facilitating DNA double-strand break repair.
    Dumitrache LC; Hu L; Son MY; Li H; Wesevich A; Scully R; Stark J; Hasty P
    Genetics; 2011 Aug; 188(4):787-97. PubMed ID: 21546543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limiting the persistence of a chromosome break diminishes its mutagenic potential.
    Bennardo N; Gunn A; Cheng A; Hasty P; Stark JM
    PLoS Genet; 2009 Oct; 5(10):e1000683. PubMed ID: 19834534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREX1 acts in degrading damaged DNA from drug-treated tumor cells.
    Wang CJ; Lam W; Bussom S; Chang HM; Cheng YC
    DNA Repair (Amst); 2009 Oct; 8(10):1179-89. PubMed ID: 19617005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological vis-a-vis biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt-ATP on experimental animal models.
    Pal S; Sadhu AS; Patra S; Mukherjea KK
    J Exp Clin Cancer Res; 2008 Nov; 27(1):68. PubMed ID: 19014472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative DNA binding and communication across the dimer interface in the TREX2 3' --> 5'-exonuclease.
    Perrino FW; de Silva U; Harvey S; Pryor EE; Cole DW; Hollis T
    J Biol Chem; 2008 Aug; 283(31):21441-52. PubMed ID: 18534978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin depletes TREX2 and causes Robertsonian translocations as seen in TREX2 knockout cells.
    Chen MJ; Dumitrache LC; Wangsa D; Ma SM; Padilla-Nash H; Ried T; Hasty P
    Cancer Res; 2007 Oct; 67(19):9077-83. PubMed ID: 17909011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREX2 exonuclease defective cells exhibit double-strand breaks and chromosomal fragments but not Robertsonian translocations.
    Dumitrache LC; Hu L; Hasty P
    Mutat Res; 2009 Mar; 662(1-2):84-7. PubMed ID: 19094998
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.